Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: A new type of hereditary metabolic chorioretinopathy

Ophthalmology

Volumn 105, Issue 5, 1998, Pages 810-824

  Tyni, Tiina ^a,c   Kivelä, Tero ^a   Lappi, Marjatta ^a   Summanen, Paula ^a   Nikoskelainen, Eeva ^b   Pihko, Helena ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE;

ADOLESCENT; ADULT; ARTICLE; CATARACT; CHILD; CHORIORETINOPATHY; CHOROID CAPILLARY LAYER; CHOROID GYRATE ATROPHY; CLINICAL ARTICLE; COLOR VISION DEFECT; DIET THERAPY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME DEFICIENCY; FATTY ACID OXIDATION; FEMALE; GENE MUTATION; GENETIC COUNSELING; HUMAN; INFANT; MALE; MYOPIA; PIGMENT EPITHELIUM; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCOTOMA; VISUAL FIELD DEFECT;

EID: 0031956979     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(98)95019-9     Document Type: Article

References (37)

1. Wanders RJ, Duran M, Ijlst L, et al. Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase. Lancet 1989;2:52-3.
2. Wanders RJ, IJlst L, van Gennip AH, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn inborn error of mitochondrial fatty acid β-oxidation. J Inherit Metab Dis 1990;13:311-4.
3. Bertini E, Dionisi-Vici C, Garavaglia B, et al. Peripheral sensory-motor polyneuropathy, pigmentary retinopathy, and fatal cardiomyopathy in long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency. Eur J Pediatr 1992; 151:121-6.
4. IJlst L, Uskikubo S, Kamijo T, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: high frequency of the G1528C mutation with no apparent correlation with the clinical phenotype. J Inherit Metab Dis 1995;18:241-4.
5. Przyrembel H, Jakobs C, Ijlst L, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 1991;14:674-80.
6. Poll-The BT, Bonnefont JP, Ogier H, et al. Familial hypoketotic hypoglycaemia associated with peripheral neuropathy, pigmentary retinopathy and C6-C14 hydroxydicarboxylic aciduria. A new defect in fatty acid oxidation? J Inherit Metab Dis 1988;11(Suppl 2):183-5.
7. Pons R, Roig M, Riudor E, et al. The clinical spectrum of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Neurol 1996;14:236-43.
8. Riudor E, Ribes A, Boronat M, et al. A new case of C6-C14 dicarboxylic aciduria with favourable evolution. J Inher Metab Dis 1986;11(Suppl 2):297-9.
9. Vici CD, Burlina AB, Bertini E, et al. Progressive neuropathy and recurrent myoglobinuria in a child with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. J Pediatr 1991;118:744-6.
10. Wanders RJ, Ijlst L, Duran M, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: different clinical expression in three unrelated patients. J Inherit Metab Dis 1991;14:325-8.
11. Duran M, Wanders RJ, deJager JP, et al. 3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: protective effect of medium-chain triglyceride treatment. Eur J Pediatr 1991;150:190-5.
12. Moore R, Glasgow JF, Bingham MA, et al. Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency-diagnosis, plasma carnitine fractions and management in a further patient. Eur J Pediatr 1993;152:433-6.
13. Roe CR, Coates PM. Mitochondrial fatty acid oxidation disorders. In: Scriver CR, et al, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th ed. New York: McGraw-Hill. Health Profession Division, 1995; v. 1, chap 45.
14. Carpenter K, Pollitt RJ, Middleton B. Human liver long-chain 3-hydroxyacyl-coenzyme A dehydrogenase is a multifunctional membrane-bound beta-oxidation enzyme of mitochondria. Biochem Biophys Res Commun 1992; 183:443-8.
15. Uchida Y, Izai K, Orii T, Hashimoto T. Novel fatty acid β-oxidation enzymes in rat liver mitochondria. II. Purification and properties of enoyl-coenzyme A (CoA) hydratase/3-hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase trifunctional protein. J Biol Chem 1992;267:1034-41.
16. Ijlst L, Wanders RJ, Ushikubo S, et al. Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of the major disease-causing mutation in the alpha-subunit of the mitochondrial trifunctional protein. Biochim Biophys Acta 1994;1215:347-50.
17. Ijlst L, Ruiter JP, Hoovers JM, et al. Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. J Clin Invest 1996;98:1028-33.
18. Yang BZ, Heng HH, Ding JH, Roe CR. The genes for the α and β subunits of the mitochondrial trifunctional protein are both located in the same region of human chromosome 2p23. Genomics 1996;37:141-3.
19. Jackson S, Kler RS, Bartlett K, et al. Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest 1992;90:1219-25.
20. Brackett JC, Sims HF, Rinaldo P, et al. Two α subunit donor splice site mutations cause human trifunctional protein deficiency. J Clin Invest 1995;95:2076-82.
21. Kamijo T, Wanders RJA, Saudubray JM, et al. Mitochondrial trifunctional protein deficiency. Catalytic heterogeneity of the mutant enzyme in two patients. J Clin Invest 1994;93:1740-7.
22. Ushikubo S, Aoyama T, Kamijo T, et al. Molecular characterization of mitochondrial trifunctional protein deficiency: formation of the enzyme complex is important for stabilization of both alpha- and beta-subunits. Am J Hum Genet 1996;58:979-88.
23. Wanders RJA, Ijlst L, Poggi F, et al. Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid β-oxidation. Biochem Biophys Res Commun 1992; 188:1139-45.
24. Venizelos N, Ijlst L, Wanders RJ, Hagenfeldt L. Oxidation enzymes in fibroblasts from patients with 3-hydroxydicarboxylic aciduria. Pediatr Res 1994;36(1 Pt 1):111-4.
25. Tyni T, Palotie A, Viinikka L, et al. Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patients. J Pediatr 1997;130:67-76.
26. Marmor MF, McNamara JA. Pattern dystrophy of the retinal pigment epithelium and geographic atrophy of the macula. Am J Ophthalmol 1996;122:382-92.
27. Newsome DA. Retinal dystrophies and degenerations. New York: Raven Press, 1988;195-231.
28. Wolf U. Identical mutations and phenotypic variation. Hum Genet 1997;100:305-21.
29. Mulders JW, Hendriks W, Blankesteijn WM, et al. λ-Crystallin, a major rabbit lens protein, is related to hydroxyacyl-coenzyme A dehydrogenases. J Biol Chem 1988;263: 15462-6.
30. Kaiser-Kupfer MI, Ludwig IH, deMonasterio FM, et al. Gyrate atrophy of the choroid and retina. Early findings. Ophthalmology 1985;92:394-401.
31. Kärnä J. Choroideremia: a clinical and genetic study of 84 Finnish patients and 126 female carriers. Acta Ophthalmol Suppl (Copenh) 1986;176:1-68.
32. Schaefer J, Jackson S, Dick DJ, Turnbull DM. Trifunctional enzyme deficiency: adult presentation of a usually fatal β-oxidation defect. Ann Neurol 1996;40:597-602.
33. Eustis HS, Curry T, Superneau DW. Peroxisomal bifunctional enzyme complex deficiency with associated retinal findings. J Pediatr Ophthalmol Strabismus 1995;32:125-7.
34. Folz S, Trobe J. The peroxisome and the eye. Surv Ophthalmol 1991;35:353-68.
35. McCulloch C. Choroideremia and other choroidal atrophies. In: Newsome DA, ed. Retinal Dystrophies and Degenerations. New York: Raven Press, 1988;285-95.
36. Godley BF, Tiffin PA, Evans K, et al. Clinical features of progressive bifocal chorioretinal atrophy: a retinal dystrophy linked to chromosome 6q. Ophthalmology 1996; 103:893-8.
37. Curtin BJ. The myopias: basic science and clinical management. Philadelphia: Harper & Row, 1985.